Cipla Europe NV, a wholly-owned subsidiary of Cipla Ltd on 20 November 2014 tied up with Serum Institute of India Ltd (SII) to distribute vaccines in Europe.
Under the agreement, SII will develop and manufacture paediatric vaccines. On the other hand, Cipla will seek European Medicines Agency approval and market the products in Europe.
Serum Institute of India Ltd (SII)
Serum Institute of India was founded in 1966 with the aim of manufacturing life-saving immuno-biologicals, which were in shortage in the country and imported at high prices.
Today, Serum Institute of India Ltd is the World's largest producer of Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines.
Vaccines manufactured by the Serum Institute are accredited by the World Health Organization and are being used in around 140 countries across the globe in their national immunization programs.
Who: Cipla Europe NV
When: 20 November 2014
DISCLAIMER: JPL and its affiliates shall have no liability for any views, thoughts and comments expressed on this article.
Eight-foot bronze statue of World War II Indian pilot Mohinder Singh Pujji unveiled in UK
PV Sindhu won 2014 Macau Open Grand Prix Gold Badminton Title
CERN scientists discovered two subatomic particles belonging to the family of baryon
Book titled Letters for a Nation written by Jawaharlal Nehru & Madhav Khosla